Crcdc-Cvl
Tours, France, 37000
Location contact
Julie BOYARD, ScD
CONTACT
749702336 ext. +33
Julie BOYARD, ScD
PRINCIPAL_INVESTIGATOR
Somany VIDAL-SENGCHANH-VIDAL
CONTACT
NCT Number: NCT07520578
To be effective, organized colorectal cancer screening requires good adherence to diagnostic colonoscopy in the event of a positive test. In France, the rate of diagnostic colonoscopy following a positive colorectal cancer screening test is less than 85%, and the median delay is close to 90 days. After receiving their positive result from the laboratory, individuals with no known follow-up are contacted only six months later by the Regional Cancer Screening Coordination Centers (CRCDC) responsible for following up with individuals who have tested positive. To optimize follow-up with colonoscopy, earlier contact and information about colonoscopy appear to be necessary. The contribution of the general practitioner identified on the test could be an additional lever.
The SUIVICOLO study aims to evaluate the effectiveness on the rate of colonoscopies performed at 6 months of two strategies for optimizing the follow-up of positive results in comparison with control group C (current procedures of the CRCDC Centre Val de Loire without early letter).
The two strategies evaluated will be:
* Group B1: Sending an early letter signed by the CRCDC accompanied by information leaflet about colonoscopy * Group B2: Sending an early letter co-signed by the CRCDC and the general practitioner (identified or provided by the patient on the test identification form) accompanied by information leaflet about colonoscopy.
These strategies will be compared to the current follow-up strategy in a three arm randomized controlled arm.
Trial opening soon.
Get Notified50 year–75 year
All sexes
Interventional
Phase 3
Tours, France, 37000
Julie BOYARD, ScD
CONTACT
749702336 ext. +33
Julie BOYARD, ScD
PRINCIPAL_INVESTIGATOR
Somany VIDAL-SENGCHANH-VIDAL
CONTACT
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
An information leaflet about colonoscopy follow-up will be sent in an early letter 7 days after positive test result, and though QR-codes in subsequent reminders.
Explicit mention of their general practitioner in letters and reminders sent by the CRCDC to individuals who have tested positive for colorectal cancer, including the information leaflet about colonoscopy or a link to this document (QR code).
Time frame: 6 months
Time frame: At baseline
Time frame: 12 months
Time frame: 18 months
Time frame: 24 months
Time frame: 24 months
Time frame: 24 months
Time frame: 24 months
Time frame: 24 months
Time frame: 24 months
Time frame: 24 months
Time frame: 24 months
Time frame: 24 months
Contact information is provided by the study sponsor or research team.
University Hospital, Caen
Other
EFFECTIVENESS OF EARLY INFORMATION AND ENDORSMENT BY GP TO INCREASE COLONOSCOPY FOLLOW-UP AND REDUCE DELAYS IN PEOPLE WITH A POSITIVE COLORECTAL CANCER SCREENING TEST, A RANDOMISED CONTROLLED TRIAL. (SUIVICOLO)
Acronym: SUIVICOLO
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07522177
Colorectal Cancer Screening
Stanford, California, United States
View Trial DetailsNCT07183046
Colorectal Cancer Screening, Fecal Immunochemical Test
Lebanon, New Hampshire, United States
View Trial DetailsNCT07639554
Colorectal Cancer Screening
Champlitte, Franche-comté, France
View Trial DetailsNCT07606963
Colonic Diseases, Colonoscopy
Tychy, Silesian Voivodeship, Poland
View Trial Details